Nucleix: NHS Lothian and Nucleix Presented Data at EAU25 Showcasing Potential of Bladder EpiCheck to Improve Detection of Disease Recurrence in Non-Muscle Invasive Bladder Cancer (NMIBC) Patients

Adding Bladder EpiCheck® to surveillance cystoscopies in high-risk non-muscle invasive bladder cancer (NMIBC) patients increased the detection of High-Grade recurrences by 65% Bladder EpiCheck det...